Mega menu

Home
Product regulation
Product regulation

Understand your obligations and access industry Guidance and other information about the products we regulate.
Safety and shortages
Safety and shortages

Access information about product recalls, shortages and other alerts, and learn how we manage safety.
Resources and guidance
Resources and guidance

Get information to help you understand our work, regulations and industry obligations.
Business services
Business services

Access our systems to submit applications, manage forms, make payments and communicate securely.

Accelagen Pty Ltd

Regulatory activities for this sponsor.

- LinkedIn
- (Twitter)
- Facebook
- Email

Loading...

Type

ARTG (57)
Prescription medicine registration (27)
Cancellation by sponsor (5)
Australian public assessment report (AusPar) (1)
COVID-19 test kit (1)
Prescription medicine evaluation (1)

Date

2026 (20)
2025 (13)
2023 (1)
2022 (19)
2021 (13)
2020 (16)
2019 (3)
2016 (3)
2001 (4)

Search

Sponsor content

92 result(s) found, displaying 61 to 70

AMBRISENTAN MSN (Accelagen Pty Ltd)

4 March 2022

Prescription medicine registration

Active ingredients: ambrisentan.
DEFERASIROX FCT MSN (Accelagen Pty Ltd)

3 March 2022

Prescription medicine registration

Active ingredients: deferasirox.
TALMINEX oseltamivir (as phosphate) 45 mg capsule blister pack (312889)

25 February 2020

ARTG

Australian Register of Therapeutic Goods (ARTG) information for TALMINEX oseltamivir (as phosphate) 45 mg capsule blister pack.
TALMINEX oseltamivir (as phosphate) 30 mg capsule blister pack (312888)

25 February 2020

ARTG

Australian Register of Therapeutic Goods (ARTG) information for TALMINEX oseltamivir (as phosphate) 30 mg capsule blister pack.
TALMINEX oseltamivir (as phosphate) 75 mg capsule blister pack (312887)

25 February 2020

ARTG

Australian Register of Therapeutic Goods (ARTG) information for TALMINEX oseltamivir (as phosphate) 75 mg capsule blister pack.
LACOSAMIDE MSN (Accelagen Pty Ltd)

20 January 2022

Prescription medicine registration

Active ingredients: lacosamide.
LACOSAMIDE MSN (Accelagen Pty Ltd)

20 January 2022

Prescription medicine registration

Active ingredients: lacosamide.
MSN-SOLIFENACIN solifenacin succinate 5 mg film-coated tablet blister pack (314023)

10 January 2020

ARTG

Australian Register of Therapeutic Goods (ARTG) information for MSN-SOLIFENACIN solifenacin succinate 5 mg film-coated tablet blister pack.
MSN-SOLIFENACIN solifenacin succinate 10 mg film-coated tablet blister pack (314024)

10 January 2020

ARTG

Australian Register of Therapeutic Goods (ARTG) information for MSN-SOLIFENACIN solifenacin succinate 10 mg film-coated tablet blister pack.
AZACITIDINE MSN; AZACITIDINE SANDOZ (Accelagen Pty Ltd)

20 October 2021

Prescription medicine registration

Active ingredients: azacitidine.

Pages

First page
Previous page
…
Page 2
Page 3
Page 4
Page 5
Page 6
Current page 7
Page 8
Page 9
Page 10
Next page
Last page

Using our website

Accessibility
Privacy
Security
Disclaimer
Copyright
Freedom of information
Acronyms and glossary terms

Quick links

Search our databases
Report a problem or side effect
TGA Business Services
Special Access Scheme
Authorised Prescriber
Office of Drug Control
State and territory contacts

Connect with us

Email subscriptions
Contact us
Facebook
(formerly Twitter)
Youtube
Instagram
LinkedIn

Help us improve

We are always looking for ways to improve our website.

Provide feedback

The Department of Health, Disability and Ageing acknowledges First Nations peoples as the Traditional Owners of Country throughout Australia, and their continuing connection to land, sea and community. We pay our respects to them and their cultures, and to all Elders both past and present.